This property may reflect its ability to inhibit CXCL10, a known, early contributor to SSc-associated vasculopathy, effectively preventing activation of endothelial cells and dermal fibroblasts in patients with SSc [8]. Here, CXCL10 is linked to systemic sclerosis.